Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers: A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Singapore
Springer Nature Singapore
2024
Singapore Springer |
| Ausgabe: | 1st ed. 2024 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 Online-Ressource (XIV, 602 p. 25 illus) |
| ISBN: | 9789819773800 |
| DOI: | 10.1007/978-981-97-7380-0 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV049935195 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 241104s2024 xx o|||| 00||| eng d | ||
| 020 | |a 9789819773800 |c Online |9 978-981-9773-80-0 | ||
| 024 | 7 | |a 10.1007/978-981-97-7380-0 |2 doi | |
| 035 | |a (ZDB-2-SME)9789819773800 | ||
| 035 | |a (OCoLC)1466904828 | ||
| 035 | |a (DE-599)BVBBV049935195 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-578 | ||
| 082 | 0 | |a 615 |2 23 | |
| 084 | |a MED 000 |2 stub | ||
| 245 | 1 | 0 | |a Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers |b A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview |c edited by Mukesh Nandave |
| 250 | |a 1st ed. 2024 | ||
| 264 | 1 | |a Singapore |b Springer Nature Singapore |c 2024 | |
| 264 | 1 | |a Singapore |b Springer | |
| 300 | |a 1 Online-Ressource (XIV, 602 p. 25 illus) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 650 | 4 | |a Pharmacology | |
| 650 | 4 | |a Drug Safety and Pharmacovigilance | |
| 650 | 4 | |a Biomedical Research | |
| 650 | 4 | |a Medical Biochemistry | |
| 650 | 4 | |a Therapeutics | |
| 650 | 4 | |a Pharmacology | |
| 650 | 4 | |a Pharmacovigilance | |
| 650 | 4 | |a Medicine / Research | |
| 650 | 4 | |a Biology / Research | |
| 650 | 4 | |a Clinical biochemistry | |
| 650 | 4 | |a Therapeutics | |
| 700 | 1 | |a Nandave, Mukesh |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-981-9773-79-4 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-981-9773-81-7 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-981-9773-82-4 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-97-7380-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_2024 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-035273519 | |
Datensatz im Suchindex
| _version_ | 1817704375725850624 |
|---|---|
| adam_text | |
| any_adam_object | |
| author2 | Nandave, Mukesh |
| author2_role | edt |
| author2_variant | m n mn |
| author_facet | Nandave, Mukesh |
| building | Verbundindex |
| bvnumber | BV049935195 |
| classification_tum | MED 000 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)9789819773800 (OCoLC)1466904828 (DE-599)BVBBV049935195 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-981-97-7380-0 |
| edition | 1st ed. 2024 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV049935195</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">241104s2024 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789819773800</subfield><subfield code="c">Online</subfield><subfield code="9">978-981-9773-80-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-981-97-7380-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)9789819773800</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1466904828</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049935195</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-578</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 000</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers</subfield><subfield code="b">A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview</subfield><subfield code="c">edited by Mukesh Nandave</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2024</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore</subfield><subfield code="b">Springer Nature Singapore</subfield><subfield code="c">2024</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore</subfield><subfield code="b">Springer</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 602 p. 25 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Safety and Pharmacovigilance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedical Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapeutics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacovigilance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine / Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biology / Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapeutics</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nandave, Mukesh</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-981-9773-79-4</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-981-9773-81-7</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-981-9773-82-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-981-97-7380-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2024</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-035273519</subfield></datafield></record></collection> |
| id | DE-604.BV049935195 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-06T15:12:57Z |
| institution | BVB |
| isbn | 9789819773800 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-035273519 |
| oclc_num | 1466904828 |
| open_access_boolean | |
| owner | DE-578 |
| owner_facet | DE-578 |
| physical | 1 Online-Ressource (XIV, 602 p. 25 illus) |
| psigel | ZDB-2-SME ZDB-2-SME_2024 |
| publishDate | 2024 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Springer Nature Singapore Springer |
| record_format | marc |
| spelling | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview edited by Mukesh Nandave 1st ed. 2024 Singapore Springer Nature Singapore 2024 Singapore Springer 1 Online-Ressource (XIV, 602 p. 25 illus) txt rdacontent c rdamedia cr rdacarrier Pharmacology Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry Therapeutics Pharmacovigilance Medicine / Research Biology / Research Clinical biochemistry Nandave, Mukesh edt Erscheint auch als Druck-Ausgabe 978-981-9773-79-4 Erscheint auch als Druck-Ausgabe 978-981-9773-81-7 Erscheint auch als Druck-Ausgabe 978-981-9773-82-4 https://doi.org/10.1007/978-981-97-7380-0 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview Pharmacology Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry Therapeutics Pharmacovigilance Medicine / Research Biology / Research Clinical biochemistry |
| title | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview |
| title_auth | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview |
| title_exact_search | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview |
| title_full | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview edited by Mukesh Nandave |
| title_fullStr | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview edited by Mukesh Nandave |
| title_full_unstemmed | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview edited by Mukesh Nandave |
| title_short | Angiotensin-converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers |
| title_sort | angiotensin converting enzyme inhibitors vs angiotensin receptor blockers a critical analysis of antihypertensive strategies a machine generated literature overview |
| title_sub | A Critical Analysis of Antihypertensive Strategies: A Machine-Generated Literature Overview |
| topic | Pharmacology Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry Therapeutics Pharmacovigilance Medicine / Research Biology / Research Clinical biochemistry |
| topic_facet | Pharmacology Drug Safety and Pharmacovigilance Biomedical Research Medical Biochemistry Therapeutics Pharmacovigilance Medicine / Research Biology / Research Clinical biochemistry |
| url | https://doi.org/10.1007/978-981-97-7380-0 |
| work_keys_str_mv | AT nandavemukesh angiotensinconvertingenzymeinhibitorsvsangiotensinreceptorblockersacriticalanalysisofantihypertensivestrategiesamachinegeneratedliteratureoverview |